Log In
BCIQ
Print this Print this
 

DTX201, DTX201 AAV FVIII

  Manage Alerts
Collapse Summary General Information
Company Dimension Therapeutics Inc.
DescriptionAdeno-associated viral (AAV) vector delivering Factor VIII
Molecular Target Factor VIII
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A
Regulatory Designation
PartnerBayer AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
Get a free BioCentury trial today